Harbour BioMed

.VC

Enhanced Group Secures $50 Million Financing to Accelerate Health Platform Growth

NEW YORK, June 15, 2026 Enhanced Group Inc. has announced a $50 million strategic equity financing through a private...

By cGxPwire Editor
June 16, 2026

.Tech

Harbour BioMed and BioMap Unveil AI-Powered MegaStream TechBio Platform

CAMBRIDGE, Mass., ROTTERDAM, Netherlands, and SHANGHAI, China, June 15, 2026 Harbour BioMed and BioMap have announced a long-term strategic...

By cGxPwire Editor
June 16, 2026

Bio-Pharma

Harbour BioMed Secures Major Antibody Patent Victory Over Amgen

CAMBRIDGE, Massachusetts, ROTTERDAM, Netherlands, and SHANGHAI, China, June 14, 2026 Harbour BioMed has secured a major legal victory in...

By cGxPwire Editor
June 15, 2026

.Clinical

Harbour BioMed Clears Regulatory Milestone for HBM7004

CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; SHANGHAI, China, June 10, 2026 Harbour BioMed announced that the National Medical Products Administration (NMPA)...

By cGxPwire Editor
June 10, 2026

.Clinical

Harbour BioMed Reports Strong Preclinical Results for AI-Designed Obesity Drug LET003

CAMBRIDGE, Massachusetts; ROTTERDAM, Netherlands; and SHANGHAI, China, May 18, 2026 Harbour BioMed announced promising preclinical data for LET003, its...